JavaScript is unavailable or disabled; so you are probably going to miss out on a few things. Everything should still work, but with a little less pzazz! Skip to main content
The William Harvey Research Institute - Faculty of Medicine and Dentistry

Clinical disease activity and modulation of synovial lymphoid structures and B cell function in RA (Anti-TNF Study)

[REC Ref. No. 10/H0801/47]

Status: Closed to recruitment

The main aim of this study is to assess the relationship between the presence of ectopic

lymphoneogenesis (ELN) within the rheumatoid synovial membrane and clinical disease activity.

We hypothesised that ELN evolves over time and may correlate with clinical disease activity. This study provided an opportunity to document that change and relate it to patient’s clinical progression during an established, active phase of their disease. Patients at this juncture often require more aggressive therapy, such as anti-TNF agents. We planned to enroll patients at this stage of their disease and perform a synovial biopsy at Visit 1 (-4 - -1 weeks) and at Visit 5 (week 12). Patients were treated with either certolizumab or etanercept. Results of the study can be found here.

Anti-TNF Bio & Data-Resource Metrics

74 patients were recruited to this study. A synovial biopsy was performed prior to anti-TNF treatment and at week 12. Samples bio-banked include FFPE synovial tissue (pre- and post-treatment) and blood.

 

 

 

Back to top